Professional affiliation
Ferran Torres, MD, PhD
Short Professional Extract
Ferran Torres (1964-), MD, PhD Medical doctor (1988), Clinical Pharmacology medical speciality (1992), PhD (Methodological and Statistical Issues of Sequential Clinical Trials, 1998), with more than 20 years experience in the design and analysis of clinical trials and other studies in the hospital and university settings (1992-).
Current work:
Scientific Director of the Medical Statistics core facility, IDIBAPS – Hospital Clinic, Barcelona (2007-).
Associate professor at the Biostatistics Unit, Faculty Medicine, Universitat Autònoma de Barcelona (UAB, 1994-).
Publications:
More than 150 published papers in indexed scientific journals with a cumulated IF of >700 (1993 to 2014). [Pubs from 2000-].
Collaboration with Scientific Journals:
Associate editor of the Trials Journal (2015-); Statistical Advisory Board of PlosOne; Peer reviewer for a number of scientific journals (Journal of Biopharmaceutical Statistics, Clinical Rheumatology, Trials, European Journal of Clinical Pharmacology, Medicina Clínica, Archivos de Bronconeumologia, etc.)
Regulatory Scientific & Statistics activities:
Medical and statistical consultant to the Spanish Medicines Agency (AEMPS, 1999-); member of the Scientific Advice Working Party (SAWP, 2008-) and the Biostatistics Working Party (BSWP, 2009-) groups at the European Medicines Agency (EMA).
Independent Investigation:
Active collaborator of the ECRIN network: Spanish representative to the Data Management group (2003-). Member of the Independent Certification Board (ICB), (2011-). Permanent external reviewer of the ECRIN standard procedures (2013-).
Coordinator of the Biostatistics and Data Management Program of the Spanish Clinical Research Network (SCReN), Platform funded by the ISCiii to promote the independent clinical investigation (2013-) Plataforma de Unidades de Investigación Clínica y Ensayos Clínicos (general info in spanish).
Methodologies for rare diseases:
Principal investigator of WP5 (Validation of new methods within clinical as well as regulatory settings) for the FP7 project on rare diseases ASTERIX (Advances in Small Trials dEsign for Regulatory Innovation and eXcellence ASTERIX) (2014-2018). This project is specifically designed to optimize methodology for clinical trials in small populations to achieve more reliable and cost efficient clinical development of treatments for rare diseases. (FP7-HEALTH-2013-INNOVATION-1, Grant-Agreement No. 603160).
Orphan diseases and collaboration with EURORDIS network.
Others:
Coordinator and professor to several training, doctorate courses and masters of methodological-statistical issues on clinical investigation.
ResearchGate => https://www.researchgate.net/profile/Ferran_Torres
ResearcherId: D-1296-2011 => http://www.researcherid.com/rid/D-1296-2011
ORCID: 0000-0002-7355-7913 => http://orcid.org/0000-0002-7355-7913
SCOPUS: 7102336718 => http://www.scopus.com/authid/detail.url?authorId=7102336718
